1Donnelly-Roberts DL,Puttfarcken PS,Kuntzweiler TA ,et al.ABT-594 [ ( R )-5- ( 2-azetidinylmethoxy )-2-chloropyridine ]: A novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization [J]. Journal of Pharmacology and Experimental Therapeutics, 1998,285(2):777.
3Sullivan JP, DonnellyRoberts D, Briggs CA, et a1. A-85380[3-(2(S)-azetidinylmethoxy)pyridine]: In vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand [J]. Neuropoharmacology, 1996,35(6):725.
4Hooft JA, Vijverberg HPM, Agonist and antagonist effects of apomorphine enantiomers on 5-HT3 receptors [J]. Neuropharmacology. 1998.37 (2): 259.
5Eglem RM, BonhausDW, ClarkRD, etal. (R)-RS-56532and (S)-RS-56532-mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selec:ivety [J ]. Neuropharmacology,1994,33(3-4) :515.
6Wood MD, Thoms DR, Wakins C J, et al. Stereoselective interaction of mianserin with 5-HT3 receptous [J ]. Journal of Pharmacy and Pharmacology, 1993,45(8) :711.
7Kardos J, Blandl T, Luyen ND et al. Synthesis, antiGABAactivity and preferred conformation of bicuculline and norbicuculline enantiomers [J]. European Journal of Medicinal Chemistry, 1996,31 (10) : 761.
8Knabe J, Buch HP, Bender S . 1,5-Benzodiazepines. 2. diametrically opposite CNS-effects between the enantiomers of 23, 3-dialkyl-l, 5-benzodiazepine-2, 4-diones [J ]. Archiv Der Pharmazie, 1995,328(1) :59
9Maksay G, Molnar P, Simonyi M. Hermodynamics and kinetics of t-butylbicyclophosphorothionate binding differentiate convulsant and depressant barbiturate stereoisomers acting via GABA (A) ionophores [J], Naunyn-schmiedebergs Archives of Pharmacology, 1996,353(3) :306.
10Rabben T. Effects of the N VDA receptor antagonist ketamine in electrically induced A delta-fiber pain [J]. Methods and Findings in Experimental ard Clinical Pharmacology, 2000,22(3):185.
